Tuesday, July 30, 2019 - 14:47
Sofia, Bulgaria, July 30, 2019 - Sopharma AD notifies that the Company completes H1 2019 with 10% increase of sales revenues from export markets and the main markets continue the tendency for stable growth and good performance of priority products.
Following its strategy for market diversification the company realized sales in Sweden for the first time.
“We strive to stabilize our positions on markets where we entered in the last few years and grow continuously, even though from a low base. Our aim is to diversify and build sustainable partnerships in countries like Vietnam, Tunis, Finland, etc.”, comments Mr. Ognian Donev, PhD, Executive Director and Chairman of the Board of Directors of Sopharma AD.